Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C

Journal of Hepatology

Volumn 31, Issue 6, 1999, Pages 971-978

  Lechmann, Martin ^a   Woitas, Rainer P ^a   Langhans, Bettina ^a   Kaiser, Rolf ^a   Ihlenfeldt, Hans Georg ^b   Jung, Günther ^b   Sauerbruch, Tilman ^a   Spengler, Ulrich ^a,c  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Cytokines; ELISpot; Hepatitis C; T cells

Indexed keywords

CORE PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; CHRONIC HEPATITIS; CYTOKINE RELEASE; FEMALE; HEPATITIS C; HUMAN; IMMUNE RESPONSE; IMMUNOPHENOTYPING; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIREMIA;

EID: 0032733793     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80307-9     Document Type: Article

References (35)

1. Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A, Celis E, et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus encoded peptides binding to HLA-A2.1 molecules. J Virol. 69:1995;2462-2470.
2. Koziel MJ, Dudley D, Afdahl N, Choo Q-L, Houghton M, Ralston R, et al. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol. 67:1993;7422-7532.
3. Cerny A, Ferrari C, Chisari FV. The classs I-restricted cytotoxic T lymphocyte response to predetermined epitopes in the hepatitis B and C viruses. Curr Top Microbiol Immunol. 189:1994;169-186.
4. Shirai M, Arichi T, Nishioka M, Nomura T, Ikeda K, Kawanishi K, et al. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J Immunol. 154:1995;2733-2742.
5. Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unumaaz H, Weiner AJ, et al. T-lymphocyte response to hepatitis C virus in clinical courses of infection. Gastroenterology. 104:1993;580-587.
6. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, et al. T cell response to structural and nonstructural hepatitis C virus antigen in persistent and self-limited hepatitis C virus infections. Hepatology. 19:1994;286-295.
7. Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G, Matz B, et al. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia. Hepatology. 24:1996;790-795.
8. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 136:1986;2348-2357.
9. Sornasse T, Larenas PV, Davis KA, deVries JE, Yssel HJ. Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J Exp Med. 184:1996;473-483.
10. Sad S, Marcotte R, Mosmann TR. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ cells secreting TH1 or TH2 cytokines. Immunity. 2:1995;271-279.
11. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol. 7:1989;145-173.
12. Bottomly K. A functional dichotomy in CD4+ T lymphocytes. Immunol Today. 9:1988;268-274.
13. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesion. Science. 254:1991;277-280.
14. Clerici M, Shearer GM. A TH1→TH2 switch is a critical step in the etiology of HIV infection. Immunol Today. 14:1993;107-111.
15. Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol. 10:1992;384-409.
16. ElGhazali G, Paulie S, Andersson G, Hansson Y, Holmquvist G, Sun JB, et al. Number of interleukin-4- and interferon-γ-secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: distinct response profiles depending on the type of antigen used for activation. Eur J Immunol. 23:1993;2740-2745.
17. Hagiwara E, Abbasi F, Mor G, Ishigatsubo Y, Kilnman DM. Phenotype and frequency of cells secreting IL-2, IL-4, IL-6, IL-10, IFN and IFN-α in human peripheral blood. Cytokine. 7:1996;815-822.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
19. Imberti L, Cariani E, Bettinardi A, Zonaro A, Albertini A, Primi D. An immunoassay for specific amplified HCV sequences. J Virol Meth. 34:1991;233-243.
20. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA derived from a blood-borne non-A non-B viral hepatitis genome. Science. 244:1989;359-362.
21. King DS, Fields CG, Fields GB. A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. Int J Peptide Protein Res. 36:1990;255-266.
22. Fujihashi K, McGhee JR, Beagly KW, McPherson DI, McPherson SA, Huang C-M, et al. Cytokine-specific ELISPOT assay for single cell analysis of IL-2, IL-4 and IL-6 producing cells. J Immunol Methods. 160:1993;181-189.
23. Weiner AJ, Christopherson C, Hall JE, Bonino F, Saracco G, Brunetto MR, et al. Sequence variation in hepatitis C viral isolates. J Hepatol. 13:(Suppl. 4):1991;S6-S14.
24. Tsai S-L, Liaw Y-F, Chen M-H, Huang C-Y, Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: implication for hepatitis C chronicity. Hepatology. 25:1997;449-458.
25. Trinchieri G. Biology of natural killer cells. Adv Immunol. 47:1989;187-276.
26. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM. Immunregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa. Hepatology. 24:1996;6-9.
27. Woitas R, Lechmann M, Jung G, Kaiser R, Sauerbruch T, Spengler U. CD30 induction and cytokine profiles in HCV corespecific peripheral blood T lymphocytes. J Immunol. 159:1997;1012-1018.
28. Reiser M, Marousis CG, Nelson DR, Lauer G, Gonzalez-Peralta RP, Davis GL, et al. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J Hepatol. 26:1997;471-478.
29. Malaguarnera M, Di Fazio I, Laurino A, Pistone G, Restuccia S, Trovato BA. Decrease of interferon gamma serum levels in patients with chronic hepatitis C. Biomed Pharmacother. 51:1997;391-396.
30. Osna N, Silonova G, Vigert N, Hagina E, Kuse V, Giedratis V, et al. Chronic hepatitis C: T-helper 1/T-helper2 imbalance could cause virus persitence in peripheral blood. Scand J Clin Lab Invest. 57:1997;703-710.
31. Fan XG, Liu WE, Li CZ, Wang ZC, Luo LX, Tan DM, et al. Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection. Mediators Inflamm. 7:1998;295-297.
32. Iwata K, Wakita T, Okumura A, Yoshioka K, Takayanagi M, Wands JR, et al. Interferon-gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection. Hepatology. 22:1995;1057-1064.
33. Minutello MA, Pileri PP, Unutmaz D, Censini S, Kuo G, Houghton M, et al. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis. J Exp Med. 178:1993;17-25.
34. Dumoulin FL, Bach A, Leifeld L, El Bakri M, Fischer H-P, Sauerbruch T, et al. Semiquantitative analysis of intrahepatic cytokine mRNAs in chronic hepatitis C. J Infect Dis. 175:1997;681-685.
35. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCauchghan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology. 4:1996;759-765.